Menu
Subscribe to our Email Alerts
About Us
Island at a glance
Board
Key Management
Scientific Advisory Board
Collaborations
Science
About ISLA-101
Scientific Publications
Drug repurposing and benefits
Disease and drug terms explained
Investor Centre
Investor Welcome
Clinical programme
ASX Announcements
Financial Reports
Share Price Information
Shareholder Services
Investor Fact Sheet
Corporate Governance
Corporate Directory
International Investors
Research Coverage
AGM
Media
News
Presentations
Contact
Contact Us
Subscribe for Email Alerts
Media
Media
>
News
News
Presentations
News
Filter by Year:
2023
2022
2021
2020
1-Dec-2023
Island Pharmaceuticals appoints new joint company secretary
24-Nov-2023
Island Pharmaceuticals kicks off "critical" study in Dengue fight
22-Nov-2023
Island Pharma one step closer to ISLA-101 dosing
16-Nov-2023
Island Pharmaceuticals gets ready to tackle mosquito-borne diseases as warmer climate accelerates spread
12-Nov-2023
Island Pharmaceuticals initiates screening for ISLA-101 study to combat mosquito-borne disease
10-Nov-2023
Island Pharmaceuticals nets over $300,000 in R&D tax refund
6-Nov-2023
Island Pharmaceuticals gains ISLA-101 study ethics approval for dengue fever
6-Nov-2023
Island Pharma welcomes green light for ISLA-101 clinical study
1-Nov-2023
Island Pharmaceuticals granted Australian patent for ISLA-101
27-Sep-2023
Island Pharmaceuticals CEO and Managing Director Dr David Foster on ausbiz
1
2
3
Next
.png){kind=logo}
